Indivior Concludes Legacy U.S. Department of Justice Matter

Core Insights - Indivior PLC has resolved its legacy U.S. Department of Justice matter by paying a total of $295 million, which eliminates a significant liability and simplifies its capital structure [1][2]. Group 1: Financial Resolution - The payment of $295 million was made using Indivior's cash on hand, leading to the termination of the resolution agreement with the DOJ [1]. - The CEO of Indivior expressed satisfaction with reaching this milestone, emphasizing the company's commitment to integrity and compliance [2]. Group 2: Company Mission and Vision - Indivior focuses on developing medicines for opioid use disorder (OUD) and aims to transform OUD into a recognized chronic disease with evidence-based treatment accessible to all patients [2]. - The company has a pipeline of product candidates designed to expand its offerings in the OUD treatment category [2].